What does debt issuance cost amortization mean?

Non-cash amortization of capitalized costs incurred to issue debt (underwriting fees, legal costs, SEC filing fees).

Mirum Pharmaceuticals, Inc. MIRM Debt Issuance Cost Amortization

Debt Issuance Cost Amortization at other companies

Ionis PharmaceuticalsIONS

$2.35M+43.1%

TG TherapeuticsTGTX

$285K-6.3%

BridgeBio PharmaBBIO

$1.82M+12.2%

Other financials

Income statement

See full

Revenue$159.9M+43.3%

Operating income-$789.5M-5,100%

Net income-$790.2M-5,284%

EPS (diluted)-$13.43-4,377%

Balance sheet

See full

Cash & equivalents$261.5M+43.5%

Total debt$13.5M+56.4%

Total equity$242.5M+4.0%

Total assets$890.9M+29.1%

Cash flow

See full

Operating cash flow-$228.8M-11,566%

CapEx$664.0K+1,520%

Free cash flow-$229.4M-11,360%

Valuation

See full

Market cap$6.53B+152%

Enterprise value$6.28B+162%

P/S11.5×+4.6×

Profitability

See full

Operating margin-139.8%-168pp

Net margin-140.2%-169pp

FCF margin-30.3%—

Returns & leverage

See full

Return on equity-335.8%-377pp

Debt / equity0.1×0.0×

Current ratio2.1×-1.1×

Where this comes from

Reported directly by Mirum Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCostsAndDiscounts.

The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mirum Pharmaceuticals, Inc.'s debt issuance cost amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Mirum Pharmaceuticals, Inc.'s debt issuance cost amortization?: Mirum Pharmaceuticals, Inc. (MIRM) reported debt issuance cost amortization of $454K in Q1 2026.
How has Mirum Pharmaceuticals, Inc.'s debt issuance cost amortization changed year-over-year?: Mirum Pharmaceuticals, Inc.'s debt issuance cost amortization increased by 4.8% year-over-year, from $433K to $454K.
What does debt issuance cost amortization mean?: Non-cash amortization of capitalized costs incurred to issue debt (underwriting fees, legal costs, SEC filing fees).